SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Amicus Therapeutics, Inc. with ARYA Sciences Acquisition Corp IVNewsfile Corp • 10/04/21
Amcius (FOLD) to Spin-Off Gene Therapy Arm, Form New Firm With ARYAZacks Investment Research • 09/30/21
Amicus stock is up 5%, the day after announcing plans to sell its gene therapy businessMarket Watch • 09/30/21
Amicus Therapeutics, Inc. (FOLD) on Formation of Caritas Therapeutics Conference Call (Transcript)Seeking Alpha • 09/29/21
U.S. FDA Accepts Filings for Amicus' AT-GAA for the Treatment of Pompe DiseaseGlobeNewsWire • 09/29/21
Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”GlobeNewsWire • 09/29/21
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021GlobeNewsWire • 09/03/21
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/06/21
Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate UpdatesGlobeNewsWire • 08/05/21
Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry DiseaseGlobeNewsWire • 08/02/21
Analysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 07/29/21
Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021GlobeNewsWire • 07/27/21
Amicus Therapeutics Announces United Kingdom's MHRA Grants Early Access to AT-GAAGlobeNewsWire • 06/08/21
Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare ConferenceGlobeNewsWire • 05/28/21
Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular DiseasesGlobeNewsWire • 05/21/21